23
26
OCT
2024

Botton-Champalimaud

International Pancreatic Cancer Conference

23
26
OCT
2024

Botton-Champalimaud

International Pancreatic Cancer Conference

23
26
OCT
2024

Botton-Champalimaud

International Pancreatic Cancer Conference

Partners
Scientific Sponsorship
Supported by
00
Days
00
HOurs
00
Min
00
Sec

Important Dates

May, 6th

Registration opens

07 de setembro 2022

Apresentação do congresso à Indústria

October, 4th

Registration deadline

The Conference

This conference stands as a landmark event for the Botton-Champalimaud Pancreatic Cancer Centre in 2024 and will unite leading minds in translational science, oncology and surgery to tackle the complexities of pancreatic cancer.

The conference will serve as a pivotal platform for the exchange of groundbreaking insights, state-of-the-art surgical methodologies, and innovative therapeutic approaches that will ultimately enhance patient care and outcomes on a global scale.

More than 400 participants are expected in Lisbon for the 3-day multi-track event that will bring together 95 world-renowned cancer specialists for what will be an extremely stimulating scientific conference.

See more

Local Organizer of 8th IWFC

International Liaison Committee for the 8th IWFC

Botton-Champalimaud International Pancreatic Cancer Conference

Register here

Em destaque

No items found.

Botton-Champalimaud Pancreatic Cancer Centre

Lisbon

The Botton-Champalimaud Pancreatic Cancer Centre - resulting from a partnership between the Champalimaud Foundation and the Mauricio and Charlotte Botton couple, is the first in the world simultaneously dedicated to the research and treatment of pancreatic cancer.

Combining state of the art services and equipment, aimed at guaranteeing the well-being and comfort of patients, supported by the most advanced techniques, and resulting from an exclusive aesthetic approach, this centre comprises areas of research laboratories, a day hospital, a surgical centre, as well as inpatient and intensive care facilities.

Botton-Champalimaud Pancreatic Cancer Centre

The Botton-Champalimaud Pancreatic Cancer Centre - resulting from a partnership between the Champalimaud Foundation and the Mauricio and Charlotte Botton couple, is the first in the world simultaneously dedicated to the research and treatment of pancreatic cancer.

Carmen and Reinhold Würth joined the Botton-Champalimaud Pancreatic Cancer Centre initiative in 2023 and recently inaugurated the Würth Research Centre of Hope for Pancreatic Cancer.

Combining state of the art services and equipment, aimed at guaranteeing the well-being and comfort of patients, supported by the most advanced techniques, and resulting from an exclusive aesthetic approach, this centre comprises areas of research laboratories, a day hospital, a surgical centre, as well as inpatient and intensive care facilities.

Botton-Champalimaud Pancreatic Cancer Centre

Lisbon

The Botton-Champalimaud Pancreatic Cancer Centre - resulting from a partnership between the Champalimaud Foundation and the Mauricio and Charlotte Botton couple, is the first in the world simultaneously dedicated to the research and treatment of pancreatic cancer.

Combining state of the art services and equipment, aimed at guaranteeing the well-being and comfort of patients, supported by the most advanced techniques, and resulting from an exclusive aesthetic approach, this centre comprises areas of research laboratories, a day hospital, a surgical centre, as well as inpatient and intensive care facilities.

Champalimaud Centre for the Unknown

The Champalimaud Centre for the Unknown, inaugurated on 5 October 2010, enriches the historic riverside of Belém, adjacent to the iconic Tower of Belém. This area holds significant historical value as the starting point for Portuguese explorers who ventured into the "unknown" during the 15th and 16th centuries. Today, the Centre bridges this legacy with contemporary scientific endeavors, fostering an atmosphere conducive to cutting-edge multidisciplinary research in biomedicine. Its modern architecture and functional design provide an optimal environment for scholars, researchers, and healthcare professionals from Portugal and beyond to pursue excellence and tangible outcomes.

The Champalimaud Centre for the Unknown is a state-of-the-art facility for science, medicine, technology and public use.

Botton-Champalimaud Pancreatic Cancer Centre

Lisbon

The Botton-Champalimaud Pancreatic Cancer Centre - resulting from a partnership between the Champalimaud Foundation and the Mauricio and Charlotte Botton couple, is the first in the world simultaneously dedicated to the research and treatment of pancreatic cancer.

Combining state of the art services and equipment, aimed at guaranteeing the well-being and comfort of patients, supported by the most advanced techniques, and resulting from an exclusive aesthetic approach, this centre comprises areas of research laboratories, a day hospital, a surgical centre, as well as inpatient and intensive care facilities.

Champalimaud Centre for the Unknown

The Champalimaud Centre for the Unknown, inaugurated on 5 October 2010, enriches the historic riverside of Belém, adjacent to the iconic Tower of Belém. This area holds significant historical value as the starting point for Portuguese explorers who ventured into the "unknown" during the 15th and 16th centuries. Today, the Centre bridges this legacy with contemporary scientific endeavors, fostering an atmosphere conducive to cutting-edge multidisciplinary research in biomedicine. Its modern architecture and functional design provide an optimal environment for scholars, researchers, and healthcare professionals from Portugal and beyond to pursue excellence and tangible outcomes.

The Champalimaud Centre for the Unknown is a state-of-the-art facility for science, medicine, technology and public use.

Oradores

Saiba quem vão ser os Oradores do [Nome do evento]

Ben Stanger

University of Pennsylvania Perelman School of Medicine, USA

Eileen O’Reilly

Memorial Sloan Kettering Cancer Center, USA

Rémy Nicolle

INSERM, France
By "Accepting", you agree to the storage of cookies on your device. This step helps us to improve site navigation, analyze site usage and assist in our marketing efforts. See our Privacy Policy for more information.